---
document_datetime: 2023-09-21 19:04:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zontivity-epar-all-authorised-presentations_en.pdf
document_name: zontivity-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0733638
conversion_datetime: 2025-12-22 08:43:17.259399
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------------------|
| EU/1/14/976/001  | Zontivity         | 2 mg       | Film-coated tablet    | Oral use                  | Blister (Alu/Alu)     | 7 tablets                  |
| EU/1/14/976/002  | Zontivity         | 2 mg       | Film-coated tablet    | Oral use                  | Blister (Alu/Alu)     | 10 x 1 tablets (unit dose) |
| EU/1/14/976/003  | Zontivity         | 2 mg       | Film-coated tablet    | Oral use                  | Blister (Alu/Alu)     | 28 tablets                 |
| EU/1/14/976/004  | Zontivity         | 2 mg       | Film-coated tablet    | Oral use                  | Blister (Alu/Alu)     | 30 tablets                 |
| EU/1/14/976/005  | Zontivity         | 2 mg       | Film-coated tablet    | Oral use                  | Blister (Alu/Alu)     | 50 x 1 tablets (unit dose) |
| EU/1/14/976/006  | Zontivity         | 2 mg       | Film-coated tablet    | Oral use                  | Blister (Alu/Alu)     | 100 tablets                |

Medicinal product no longer authorised